comparemela.com

Go Winter Meeting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Sinha on the Antitumor Effects of Onvansertib in a Preclinical Endometroid Endometrial Cancer Model

Nikita Sinha, MD, discusses the potential effects of onvansertib on endometroid endometrial cancer pathogenesis in a preclinical model.

Nikita sinhaDivision of gynecologic oncologyUniversity of north carolinaDepartment of obstetrics gynecologyChapel hill school of medicineSociety of gynecologic oncology winter meetingGynecologic oncologyNorth carolinaHill schoolGynecologic oncology winter meetingGo winter meetingOnclive tvEndometroid endometrial cancerOral plk1 inhibitorPreclinical model of disease

Dr Smith on the Predictive Value of CA-125 KELIM Score for Outcomes With HIPEC in Ovarian Cancer

Gabriella Smith, MD, discusses the predictive value of CA-125 KELIM score for outcomes with HIPEC during surgery in patients with epithelial ovarian cancer.

Gabriella smithSociety of gynecologic oncology winter meetingCleveland clinicGynecologic oncology winter meetingGo winter meetingOnclive tvGynecologic oncologyCa 125 kelim

Dr Haight on Predictors of Treatment Toxicity in Gynecologic Malignancies

Paulina J Haight, MD, discusses predictors of toxicity and treatment response with lenvatinib and pembrolizumab in patients with gynecologic malignancies.

Ohio state universityUnited statesPaulinaj haightOhio state university cancer centerOhio state college of medicineOhio state collegeGo winter meetingOnclive tvGynecologic oncology

Toxicities From Lenvatinib/Pembrolizumab Associated With Treatment Response in Gynecologic Malignancies

Paulina J. Haight, MD, discusses the association between the occurrence of toxicities with response to treatment with lenvatinib and pembrolizumab.

United statesPaulinaj haightSociety of gynecologic oncology winter meetingOhio state college of medicineGynecologic oncology winterOhio state collegeGynecologic oncology winter meetingOlympic valleyGo winter meetingGynecologic oncology

Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer

Danielle Krause, MD, discusses the effects of GLP-1 receptor agonist therapy in endometrial cancer.

Danielle krauseUniversity of oklahomaStephenson cancer centerOu healthGo winter meetingEndometrial cancerOnclive tv

vimarsana © 2020. All Rights Reserved.